Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Amortization of Deferred Charges (2023)

Historic Amortization of Deferred Charges for ADC Therapeutics (ADCT) over the last 1 years, with Q4 2023 value amounting to $694000.0.

  • ADC Therapeutics' Amortization of Deferred Charges changed N/A to $694000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $3.0 million, marking a year-over-year change of. This contributed to the annual value of $902000.0 for FY2024, which is 7009.28% down from last year.
  • Per ADC Therapeutics' latest filing, its Amortization of Deferred Charges stood at $694000.0 for Q4 2023.
  • In the past 5 years, ADC Therapeutics' Amortization of Deferred Charges registered a high of $830000.0 during Q1 2023, and its lowest value of $673000.0 during Q2 2023.